Dokumente
Europa English Court of Justice of the European Union CJEU
05.08.2022
Order
Biogen Netherlands v Commission
ORDER OF THE PRESIDENT OF THE GENERAL COURT 4 August 2022 (*)(Interim relief – Medicinal products for human use – Regulation (EC) No 726/2004 – Marketing authorisation for Dimethyl fumarate Polpharma – dimethyl fumarate – Application for suspension of operation of a measure – No urgency)In Case T‑269/22 R,Biogen Netherlands BV, established in Badhoevedorp (Netherlands), represented by C. Schoonderbeek, lawyer,applicant,v European Commission, represented by L. Haasbeek and A. Sipos, acting as ...
ORDER OF THE PRESIDENT OF THE GENERAL COURT 4 August 2022 (*)(Interim relief – Medicinal products for human use – Regulation (EC) No 726/2004 – Marketing authorisation for Dimethyl fumarate Polpharma – dimethyl fumarate – Application for suspension of operation of a measure – No urgency)In Case T‑269/22 R,Biogen Netherlands BV, established in Badhoevedorp (Netherlands), represented by C. Schoonderbeek, lawyer,applicant,v European Commission, represented by L. Haasbeek and A. Sipos, acting as Agents,defendant,THE PRESIDENT OF THE GENERAL COURTmakes the following Order 1 By its application based on Articles 278 and 279 TFEU, the applicant, Biogen Netherlands BV, seeks suspension of the operation of Commission Implementing Decision C(2022) 3253 final of 13 May 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for ‘Dimethyl fumarate Polpharma – dimethyl fumarate’ as a medicinal product for human use (‘the contested decision’). Background to the dispute and forms of order sought 2 The applicant is a biotechnology company which develops and markets various medicinal products, including medicinal products used in the treatment of multiple sclerosis.3 On 28 February 2012, Biogen Idec Limited lodged with the European Medicines Agency (EMA) an application for marketing authorisation, pursuant to Article 4(1) of Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March...
Angaben ohne Gewähr. Stand: 05.08.2022